---
figid: PMC3073545__nihms252607f2
figtitle: Endocannabinoids in Liver Disease
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3073545
filename: nihms252607f2.jpg
figlink: /pmc/articles/PMC3073545/figure/F2/
number: F2
caption: The major pathway is CB1 activation of lipoprotein lipase (LPL) in adipose
  tissue, resulting in increased fatty-acid (FA) release and transfer to liver ().
  Additional mechanisms mediated via hepatic CB1 receptors include increased de novo
  hepatic lipogenesis, decreased FA oxidation () and decreased secretion of TG-rich
  VLDL ().
papertitle: Endocannabinoids in Liver Disease.
reftext: Joseph Tam, et al. Hepatology. ;53(1):346-355.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9480202
figid_alias: PMC3073545__F2
figtype: Figure
redirect_from: /figures/PMC3073545__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3073545__nihms252607f2.html
  '@type': Dataset
  description: The major pathway is CB1 activation of lipoprotein lipase (LPL) in
    adipose tissue, resulting in increased fatty-acid (FA) release and transfer to
    liver (). Additional mechanisms mediated via hepatic CB1 receptors include increased
    de novo hepatic lipogenesis, decreased FA oxidation () and decreased secretion
    of TG-rich VLDL ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ft
  - kug
  - faf
  - Tg
  - de
  - whd
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - ACC
  - tacc
  - acclinal-wing
  - cb
  - Mtp
  - Mtpbeta
  - CD36
  - FAT1
  - TG
  - CPT1A
  - CPT2
  - CHPT1
  - FAS
  - FASN
  - ACACA
  - BMS1
  - ACACB
  - LPL
  - LCP1
  - MT1B
  - MTTP
  - Glycerol
---
